Bond.az White LogoBond.az Black Logo

Navitas Stock Hits Record High of $23.84

Navitas Semiconductor stock hits all-time high of $23.84. 1,104% return, $5.45B market cap. Analysis on Bond.az.

Harper Clark
ByHarper Clark- Senior Editor
|
0

Navitas Semiconductor Corp stock surged to an all-time high of $23.84, marking a remarkable year with a 1,104% total return over the past 12 months. The stock currently trades at $23.53 with a market cap of $5.45 billion.

Investor confidence is strong, driven by Navitas' innovative technologies in the semiconductor industry. However, Bond.az data suggests the stock may be overvalued, with anticipated sales declines and ongoing losses.

For more insights, including 14 additional ProTips, visit Bond.az.

More News
Today / 14:10
|
877

Semtech Stock Hits Record High: $149.4

Semtech Corporation stock hits all-time high of $149.34. 1-year gain 268%, market cap $13.81B. Analyst upgrades and new product launch.

0
Today / 14:05
|
941

Travis Perkins shareholders approve all resolutions at AGM

Travis Perkins shareholders approve all resolutions at AGM, including dividend and director elections.

0
Today / 13:43
|
623

Crown Castle names Kris Hinson as chief commercial officer

Crown Castle appoints Kris Hinson as chief commercial officer. The company announces leadership changes.

0
Today / 13:42
|
769

Parker to Buy CIRCOR Aerospace for $2.55B

Parker Hannifin acquires CIRCOR Aerospace for $2.55 billion in cash. Strategic move for the industrial giant, closing expected in H2 2026.

0
Today / 13:20
|
298

KULR partners with Factorial on drone battery integration

KULR Technology Group partners with Factorial to integrate solid-state and lithium-metal battery technologies into drone battery packs.

0
Today / 12:51
|
960

Shawbrook completes £799m mortgage securitization

Shawbrook Bank completes a £799 million mortgage securitization deal, its thirteenth, to support funding diversification and capital management.

0
Today / 12:23
|
925

Apyx Medical Reports Cellulite Treatment Clinical Data

Apyx Medical announces clinical study results on combination treatment for cellulite and skin laxity. 81.8% of patients saw improvement.

0
Today / 12:10
|
734

Arecor Grants 455,000 Stock Options

Arecor Therapeutics grants 455,000 stock options to executives under Long Term Incentive Plan. Details on vesting, performance conditions.

0
Today / 12:01
|
970

Tata Steel Gets Stay on $106M GST Dispute

India's Supreme Court stays proceedings in Tata Steel's ₹890.52 crore ($106 million) GST dispute. Read more on Bond.az.

0
Today / 11:23
|
977

Quantum Cyber Files Patent for GPS-Independent Drone System

Quantum Cyber files patent for GPS-independent drone system utilizing quantum sensor navigation and swarm defense. Stock surged 230%.

0
Today / 11:03
|
607

Retatrutide Shows 28.3% Weight Loss

Eli Lilly's retatrutide achieves 28.3% weight loss in Phase 3 TRIUMPH-1 trial. New hope for obesity treatment.

0
Today / 10:24
|
364

Immix Biopharma reports 95% complete response rate in trial

Immix Biopharma's NEXICART-2 trial achieves 95% complete response rate in AL Amyloidosis patients. Promising results for CAR-T therapy NXC-201.

0
...